Customize your JAMA Network experience by selecting one or more topics from the list below.
In the article titled “Management of Morgellons Disease With Low-Dose Trifluoperazine,”1 an error occurred in the last paragraph of the Results section concerning the number of patients who achieved at least partial responses and baseline function with median dosages of the study treatment. The sentence now reads, “Among patients with median dosages of 2 mg/d, 10 (71%) achieved at least partial responses and 7 (50%) achieved baseline function…”. The article was corrected online.
Error in Data in the Results Section. JAMA Dermatol. 2018;154(2):230. doi:10.1001/jamadermatol.2018.0104